REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 186 filers reported holding REGENXBIO INC in Q2 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $213,000 | -6.2% | 6,432 | -7.5% | 0.00% | 0.0% |
| Q4 2021 | $227,000 | -30.2% | 6,950 | -10.3% | 0.00% | -33.3% |
| Q3 2021 | $325,000 | -74.3% | 7,750 | -76.2% | 0.00% | -72.7% |
| Q2 2021 | $1,263,000 | +6.3% | 32,500 | -6.7% | 0.01% | 0.0% |
| Q1 2021 | $1,188,000 | -35.9% | 34,833 | -14.7% | 0.01% | -45.0% |
| Q4 2020 | $1,852,000 | +55.6% | 40,825 | -5.6% | 0.02% | +33.3% |
| Q3 2020 | $1,190,000 | -16.2% | 43,241 | +12.2% | 0.02% | -21.1% |
| Q2 2020 | $1,420,000 | +18.2% | 38,551 | +4.0% | 0.02% | -9.5% |
| Q1 2020 | $1,201,000 | -18.3% | 37,080 | +3.3% | 0.02% | 0.0% |
| Q4 2019 | $1,470,000 | +30.6% | 35,886 | +13.4% | 0.02% | +16.7% |
| Q3 2019 | $1,126,000 | -22.9% | 31,642 | +11.2% | 0.02% | -14.3% |
| Q2 2019 | $1,461,000 | +106.1% | 28,450 | +129.9% | 0.02% | +90.9% |
| Q1 2019 | $709,000 | – | 12,375 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic GP LLC | 743,079 | $14,854,149 | 9.91% |
| Aquilo Capital Management, LLC | 870,114 | $17,393,579 | 9.64% |
| MPM BioImpact LLC | 656,718 | $13,127,793 | 2.64% |
| ArchPoint Investors | 224,278 | $4,483,317 | 1.73% |
| Redmile Group, LLC | 2,026,576 | $40,511,254 | 1.56% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 35,396 | $707,566 | 1.36% |
| WS MANAGEMENT LLLP | 795,778 | $15,907,602 | 1.33% |
| Redwood Wealth Management Group, LLC | 14,760 | $295,052 | 0.33% |
| SummerHaven Investment Management, LLC | 21,298 | $425,747 | 0.27% |
| HARBOR CAPITAL ADVISORS, INC. | 44,106 | $881,679 | 0.18% |